Dataset Information


Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling.

ABSTRACT: K-Ras must interact primarily with the plasma membrane (PM) for its biological activity. Therefore, disrupting K-Ras PM interaction is a tractable approach to block oncogenic K-Ras activity. Here, we found that avicin G, a family of natural plant-derived triterpenoid saponins from Acacia victoriae, mislocalizes K-Ras from the PM and disrupts PM spatial organization of oncogenic K-Ras and H-Ras by depleting phosphatidylserine (PtdSer) and cholesterol contents, respectively,  at the inner PM leaflet. Avicin G also inhibits oncogenic K- and H-Ras signal output and the growth of K-Ras-addicted pancreatic and non-small cell lung cancer cells. We further identified that avicin G perturbs lysosomal activity, and disrupts cellular localization and activity of neutral and acid sphingomyelinases (SMases), resulting in elevated cellular sphingomyelin (SM) levels and altered SM distribution. Moreover, we show that neutral SMase inhibitors disrupt the PM localization of K-Ras and PtdSer and oncogenic K-Ras signaling. In sum, this study identifies avicin G as a new potent anti-Ras inhibitor, and suggests that neutral SMase can be a tractable target for developing anti-K-Ras therapeutics.


PROVIDER: S-EPMC7272413 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6737909 | BioStudies
2000-01-01 | S-EPMC1220899 | BioStudies
2018-01-01 | S-EPMC6117748 | BioStudies
1000-01-01 | S-EPMC3341555 | BioStudies
1000-01-01 | S-EPMC1305007 | BioStudies
2010-01-01 | S-EPMC2878561 | BioStudies
2019-01-01 | S-EPMC6709719 | BioStudies
1998-01-01 | S-EPMC1219346 | BioStudies
2006-01-01 | S-EPMC1386028 | BioStudies
2013-01-01 | S-EPMC3686747 | BioStudies